These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952 [TBL] [Abstract][Full Text] [Related]
30. Inflammatory myofibroblastic tumor of the urinary bladder with FN1‑ALK gene fusion: A case report. Son SM; Woo CG; Lee OJ; Kim YJ; Lee HC Oncol Lett; 2023 Jun; 25(6):227. PubMed ID: 37153035 [TBL] [Abstract][Full Text] [Related]
31. Uterine Leiomyoma-Like Inflammatory Myofibroblastic Tumor Without Myxoid Matrix or Inflammatory Cell Infiltration: A Case Report of a Potential Diagnostic Pitfall. Zhou N; Li T; Yang L; Chen L; Fu Y; Chen Y Int J Surg Pathol; 2024 Jun; 32(4):767-771. PubMed ID: 37499175 [TBL] [Abstract][Full Text] [Related]
33. Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas. Ahvenainen TV; Mäkinen NM; von Nandelstadh P; Vahteristo MEA; Pasanen AM; Bützow RC; Vahteristo PM Cancer; 2018 Dec; 124(24):4650-4656. PubMed ID: 30423196 [TBL] [Abstract][Full Text] [Related]
34. Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing. Yao Q; Bai Q; Zhang X; Ji G; Chang H; Cai X; Yu L; Wang J; Zhu X; Zhou X Arch Pathol Lab Med; 2022 Oct; 146(10):1234-1242. PubMed ID: 35041745 [TBL] [Abstract][Full Text] [Related]
35. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. Butrynski JE; D'Adamo DR; Hornick JL; Dal Cin P; Antonescu CR; Jhanwar SC; Ladanyi M; Capelletti M; Rodig SJ; Ramaiya N; Kwak EL; Clark JW; Wilner KD; Christensen JG; Jänne PA; Maki RG; Demetri GD; Shapiro GI N Engl J Med; 2010 Oct; 363(18):1727-33. PubMed ID: 20979472 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory myofibroblastic tumor of bone harboring an ALK gene amplification. Wang K; Guo R; Siegal GP; Wei S Pathol Res Pract; 2019 Sep; 215(9):152535. PubMed ID: 31326196 [TBL] [Abstract][Full Text] [Related]
38. DCTN1-ALK gene fusion in inflammatory myofibroblastic tumor (IMT) of the CNS. Vidrine DW; Berry JF; Garbuzov A; Falcon C; Tubbs RS; Bui CJ Childs Nerv Syst; 2021 Jul; 37(7):2147-2151. PubMed ID: 34014367 [TBL] [Abstract][Full Text] [Related]
39. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760 [TBL] [Abstract][Full Text] [Related]
40. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype. Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]